Cytori Therapeutics (CYTX) Misses Q4 EPS by 4c/Share

Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.74 million.

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79